Particle.news

Download on the App Store

Large GWAS Links Cannabis Use to CADM2, GRM3 and Broad Health Traits

Researchers position the work as groundwork for risk mapping toward future interventions for cannabis use disorder.

Overview

  • UC San Diego and 23andMe analyzed genotype and survey data from 131,895 participants, with frequency data from 73,374, and published the results October 13, 2025 in Molecular Psychiatry.
  • Lifetime cannabis use was associated with loci near CADM2 and GRM3, and CADM2 was also linked to frequency of use.
  • A secondary analysis identified 40 additional genes tied to lifetime use and four tied to frequency, including 29 not previously linked to cannabis-related traits.
  • Genetic liability to cannabis use correlated with 100+ psychiatric, cognitive and physical-health traits, with associations evaluated using NIH All of Us and Vanderbilt biobank datasets.
  • The study targets intermediate behaviors that precede cannabis use disorder and the authors emphasize discovery-stage findings with no FDA-approved drug treatments currently available.